Lien MY - Search Results

1

Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography-staged esophageal squamous cell carcinoma after complete resection: A population-based cohort study.

Fang HY, Lin YS, Chen CK, Chen JX, Lu TY, Huang TM, Hsieh TC, Kuo YC, Lin CY, Lien MY, Chen CC, Li CC, Chien CR. Fang HY, et al. Among authors: lien my. Thorac Cancer. 2022 Jul;13(13):1986-1993. doi: 10.1111/1759-7714.14476. Epub 2022 Jun 3. Thorac Cancer. 2022. PMID: 35661426 Free PMC article.

2

Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer.

Lien MY, Liu LC, Wang HC, Yeh MH, Chen CJ, Yeh SP, Bai LY, Liao YM, Lin CY, Hsieh CY, Lin CC, Li LY, Lin PH, Chiu CF. Lien MY, et al. Anticancer Res. 2014 Dec;34(12):7319-26. Anticancer Res. 2014. PMID: 25503167 Clinical Trial.

3

A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice.

Lin PH, Li HY, Fan SC, Yuan TH, Chen M, Hsu YH, Yang YH, Li LY, Yeh SP, Bai LY, Liao YM, Lin CY, Hsieh CY, Lin CC, Lin CH, Lien MY, Chen TT, Ni YH, Chiu CF. Lin PH, et al. Among authors: lien my. Cancer Med. 2017 Feb;6(2):349-360. doi: 10.1002/cam4.969. Epub 2017 Jan 10. Cancer Med. 2017. PMID: 28070990 Free PMC article.

4

Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors.

Guo JC, Lin CC, Lin CY, Hsieh MS, Kuo HY, Lien MY, Shao YY, Huang TC, Hsu CH. Guo JC, et al. Among authors: lien my. Anticancer Res. 2019 Oct;39(10):5675-5682. doi: 10.21873/anticanres.13765. Anticancer Res. 2019. PMID: 31570466

5

Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival.

Lien MY, Wang TH, Hsieh CY, Tsai MH, Hua CH, Cheng FM, Chung WH, Tang CH, Chia-Hsun Hsieh J. Lien MY, et al. Oral Oncol. 2021 Aug;119:105380. doi: 10.1016/j.oraloncology.2021.105380. Epub 2021 Jun 17. Oral Oncol. 2021. PMID: 34146822

6

Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites.

Guo JC, Lin CY, Lin CC, Huang TC, Lien MY, Lu LC, Kuo HY, Hsu CH. Guo JC, et al. Among authors: lien my. Oncology. 2021;99(10):652-658. doi: 10.1159/000517738. Epub 2021 Aug 2. Oncology. 2021. PMID: 34340231

7

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.

Hsieh CY, Lien MY, Lin CY, Lo WJ, Hua CH, Chang WC, Chiu CF, Lin CC. Hsieh CY, et al. Among authors: lien my. BMC Cancer. 2022 Feb 15;22(1):169. doi: 10.1186/s12885-022-09258-0. BMC Cancer. 2022. PMID: 35168547 Free PMC article. Clinical Trial.

8

Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.

Chen TT, Lin CC, Lo WJ, Hsieh CY, Lien MY, Lin CH, Lin CY, Bai LY, Chiu CF, Yeh SP. Chen TT, et al. Among authors: lien my. Int J Hematol. 2022 Apr;115(4):525-533. doi: 10.1007/s12185-021-03280-x. Epub 2022 Feb 28. Int J Hematol. 2022. PMID: 35226308

9

Visfatin Polymorphisms, Lifestyle Risk Factors and Risk of Oral Squamous Cell Carcinoma in a Cohort of Taiwanese Males.

Chen KJ, Hsieh MH, Lin YY, Chen MY, Lien MY, Yang SF, Tang CH. Chen KJ, et al. Among authors: lien my. Int J Med Sci. 2022 Apr 11;19(4):762-768. doi: 10.7150/ijms.69868. eCollection 2022. Int J Med Sci. 2022. PMID: 35582417 Free PMC article.

10

Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study.

Lin TC, Huang CH, Lien MY, Cheng FM, Li KC, Lin CY, Lin YC, Liang JA, Wang TH. Lin TC, et al. Among authors: lien my. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221107714. doi: 10.1177/15330338221107714. Technol Cancer Res Treat. 2022. PMID: 35770906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters